What You Need to Know About Targeted Cancer Therapy

by LUNGevity Foundation

This booklet discusses driver mutations and the different types of driver mutations that are known to cause cancer and are specifically seen in lung cancers. It also provides an overview of targeted therapies, including targeted therapy drugs that have been FDA approved for lung cancer, called tyrosine kinase inhibitors (TKIs). It discusses other driver mutations and their FDA-approved targeted therapies. Information on biomarker testing, how it's performed, and who and when should have their tumor tested is also discussed.